Oncology Access Director, US Market Access

About the role

The Oncology Access Director will develop and expand relationships with population health decision makers at priority accounts (including large community practices, select academic medical centers/health systems, and Oncology support organizations/societies) within a given geography. This role is accountable for leading the development of access strategies at priority accounts and within a defined geography to remove clinical, financial, and operational barriers to testing and Stemline products for patients and providers. The Oncology Access Director will serve as lead for Stemline engagement with population health decision makers and collaborate with Stemline internal stakeholders to execute a broader strategic account plan.

Responsibilities

• Serve as lead for Stemline engagement with population health decision makers (PHDMs) at priority accounts
• Develop account plans for priority accounts to ensure optimal access for Stemline products in a competitive and dynamic marketplace
• Identify competitive threats and develop response strategies to ensure optimal access to products
• Partner with external precision medicine personnel within priority accounts to identify and remove barriers to testing (BPDCN and mBC)
• Facilitate cross-functional planning for priority accounts, which includes engagement of key personnel involved in formulary/pathway/protocol decision making and ensuring all Stemline resources are used effectively to convey the value of our medicines to the accounts for their patients
• Responsible for priority account alignment across other business units and brand teams to include clear objectives, timelines, and accountability
• Compliantly engage Medical Affairs resources to support optimal product access across assigned accounts
• Partner across Market Access to understand and pull through contract opportunities (where applicable)
• Manage meeting planning and attendance to maximize the engagement and Stemline branding opportunities
• Work collaboratively with all Stemline strategic partners, including (but not limited to) Market Access, Field Sales, Medical Affairs, and Marketing
• Leverage internal resources to identify and support any reimbursement and access issues
• Provide education and services pertaining to access, coverage, coding, reimbursement, and affordability solutions for Stemline products, in a compliant and effective manner
• Plan, organize, and analyze to accomplish company and individual sales and business objectives
• Maintain ability to develop, plan specific activities, implement, monitor, and adjust all-inclusive pull-through plans that involve sales and sales leadership
• Develop and update strategic account plans for priority accounts
• Manage expenses within set budgetary guidelines
• Manage all assigned accounts through proper use of travel and administrative time
• Demonstrate ability to effectively communicate and collaborate cross-functionally
• Facilitate internal strategic account team meetings to align on common goals
• Exhibit strong oral, written, and group communication skills with both internal and external customers
• Effectively communicate with targeted accounts including C-suite customers
• Submit all budgetary information, expense reports, and administrative reports in a timely and accurate manner as requested

Qualifications

• 10+ years of proven success in biotech/pharmaceutical industry or related healthcare field
• Minimum of 5 years’ combined experience in market access customer-facing role and/or sales leadership
• Significant experience and knowledge of the community oncology and health system segments including established relationships with key decision makers
• Advanced knowledge of reimbursement and access related to provider-administered (buy/bill) and oral Oncology products including influence of pathways, payer coverage, reimbursement policies and processes, and patient services
• Oncology market access launch experience of new products/start-up experience a plus
• Demonstrated ability to collaborate with a diverse matrix of internal stakeholders (e.g., Market Access Account team, Corporate Accounts, field sales, brand marketing, Medical, legal, compliance, Trade, Patient Services, Data & Analytics) to achieve access goals
• Ability to identify future policies, practices, and trends that will affect community oncology practice management and access decision making in the marketplace
• Demonstrated ability to effectively influence without authority
• Excellent communication, presentation, and negotiation skills
• Field-based: Willingness to travel up to 50 percent of time, including some weekend availability for meetings

Skills

• In-depth knowledge of product prescribing information
• Well-developed negotiation skills
• A high level of awareness and understanding of the implications and opportunities of contract strategy
• Deep knowledge of the patient and product journey for both infused and oral oncology products
• Thorough knowledge of strategic marketing and selling
• In-depth knowledge of key account selling for targeted channels/segments
• A high level of knowledge of current reimbursement modalities, including AWP, WAC, ASP, and MAC pricing
• Thorough understanding of all corporate policies and procedures
• Thorough understanding of Patient Support and Services
• In-depth knowledge of the marketplace and applies that understanding to targeted account segment marketing, distribution strategy development, and implementation to accomplish business objectives
• The ability to influence key decision makers in targeted account segments

Benefits

• Fidelity 401(k) with company match
• Anthem Premier PPO and HDHP insurance plans
• Company-paid Basic Life & AD&D insurance
• Pre-tax FSA/HSA programs

Pay

Base Salary Range of $230,000 - $265,000 plus annual bonus and Long-Term Incentives.

Schedule

Field-based role requiring up to 50 percent travel, including some weekend availability for meetings.

About the Company

Founded in 1886 in Naples under the name of Farmacia Internazionale, Menarini moved in 1915 to Florence where the Group’s headquarters are still located today. The Menarini Group is an Italian pharmaceutical company with nearly 135 years of history, present in 70 countries with products sold in 140 locations worldwide. Its companies span from Europe to Asia, Africa, the Middle East, Central America, and the United States, where the acquisition of Stemline Therapeutics marked its entry into the US oncology market.

Menarini employs around 18,000 people and produces over 500 million packs of drugs annually across 18 manufacturing sites, including a biotech plant for monoclonal antibodies. The company has a strong commitment to oncology, with a pipeline of five investigational compounds for hematological and solid tumors. The acquisition of Stemline Therapeutics in June 2020 strengthened Menarini’s oncology portfolio, adding both commercial and clinical-stage assets.

Key products include Tagraxofusp, a novel targeted therapy for blastic plasmacytoid dendritic cell neoplasm (BPDCN) and the first approved CD123-targeted therapy in the U.S. and EU. Tagraxofusp is also being evaluated for other CD123+ indications. Menarini also commercializes Selinexor, a first-in-class oral Selective Inhibitor of Nuclear Export for hematologic cancers and solid tumors, and Elacestrant, an oral SERD approved for hormone receptor-positive advanced breast cancer.